Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases

18Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have used a phospholipase C (PLC)-deletion mutant (plcABC) of the H37Rv strain of Mycobacterium tuberculosis (MTB), as well as a plcA-insertion mutant of Mycobacterium smegmatis, to investigate the possible involvement of PLCs in clofazimine-mediated inhibition of mycobacterial K+ transport and growth. Inactivation of the PLCs of MTB and insertion of the plcA gene into M. smegmatis resulted in a substantial reduction and increase in hydrolysis of phosphatidylcholine (PC), respectively. However, both the mutant and wild-type strains of MTB and M. smegmatis were equally sensitive to the inhibitory effects of clofazimine on K+ uptake and growth. These observations demonstrate that the PLCs of MTB are not involved in the antimicrobial activity of clofazimine. © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.

Cite

CITATION STYLE

APA

Bopape, M. C., Steel, H. C., Cockeran, R., Matlola, N. M., Fourie, P. B., & Anderson, R. (2004). Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases. Journal of Antimicrobial Chemotherapy, 53(6), 971–974. https://doi.org/10.1093/jac/dkh215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free